Glycemic Index of Longan Syrup in Healthy Volunteers
Launched by CHULALONGKORN UNIVERSITY · Mar 17, 2020
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 18-60 years
- • Never diagnosis as diabetes mellitus of thyroid dysfunction
- • Fasting plasma glucose less than 100 mg/dl
- • Body mass index 18.5-24.9 kg/m2
- • Be willing to be subjects in this study
- Exclusion Criteria:
- • Know longan allergy or have history of adverse events from longan
- • Take medicines, herbs, or food supplements including thiazide diuretics, beta-blockers ,and estrogen that have an effect on blood sugar level in 1 month before this study starting
- • Severe comorbidity or uncontrolled diseases
- • Pregnancy and lactation
- • Participated in other studies
About Chulalongkorn University
Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials